In a study, the Fenofibrate Intervention and Event Lowering in Diabetes has shown that the fenofibrate is effective in controlling the diabetic retinopathy.

This made fenofibrate as the first lipid-modifying agent to demonstrate protection against diabetic retinopathy and was independent from blood glucose and blood pressure control.

FIELD, a multinational, randomized study, was conducted to evaluate whether the treatment with fenofibrate for a median of five years could reduce the macrovascular and microvascular complications.

It can be added that the Diabetic retinopathy is the situation where the retina (inner surface of the back of the eye) is progressively damaged, has affected approximately 50 million of 200 million people with diabetes worldwide.

Source: philstar.com